Novavax Reports Vaccine 90% Effective; Supply Questions Remain
Another highly effective vaccine is poised to join the fight against COVID-19. But its impact may be blunted by supply issues. The manufacturer expected to produce the bulk of the doses is in India, where the government has banned vaccine exports. FILE – A car drives past the sign for vaccine developer Novavax at the company’s headquarters in Gaithersburg, Maryland, Nov. 30, 2020.”Many of our first doses will go to … low- and middle-income countries, and that was the goal to begin with,” Novavax CEO Stanley Erck told The Associated …